Quentin Liu

机构：Sun Yat-sen University, Dalian Medical University, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China · ORCID：0000-0002-0999-9805

发表论文 314 篇 · 总被引 16140 次 · h-index 61

代表论文

• A nuclear-targeted PROTAC enables subcellular-selective degradation of AURKA (2026 · Biochemical and Biophysical Research Communications)
• ROS as a powerful instrument for the advanced cancer prevention and management: Facts and outlook (2026 · Journal of Advanced Research)
• Figure S3 from IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer (2026)
• Figure S3 from IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer (2026)
• Figure S7 from IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer (2026)
• Figure S4 from IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer (2026)